TP53 gain-of-function mutations promote osimertinib resistance via TNF-α–NF-κB signaling in EGFR-mutated lung cancer
Ritsu Ibusuki(Kyushu University), Isamu Okamoto(Kyushu University Hospital)
Cited by 36
Related Papers
Regulation of PD-L1 expression in non–small cell lung cancer by interleukin-1β
|Frontiers in Immunology|2023|20